Skip to main content

Call for papers - Biomarkers of neurological diseases

Guest Editors:
Santiago Perez-Lloret: Pontifical Catholic University of Argentina, National Research Council of Argentina
Wen-Jun Tu: Chinese Academy of Medical Sciences & Peking Union Medical College, China

Submission Status: Open   |   Submission Deadline: 28 March 2024

BMC Neurology is pleased to announce a new Collection focused on biomarkers of neurological diseases.

This Collection aims to explore how research into associated biomarkers can contribute to our understanding, diagnosis, and management of neurological conditions that affect millions of people worldwide.

SDG logo smallThis collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Meet the Guest Editors

Back to top

Santiago Perez-Lloret: Pontifical Catholic University of Argentina, National Research Council of Argentina

Santiago Perez-Lloret is a leading expert in neurophysiology and neuropharmacology, with more than 130 papers published in international medical journals. After obtaining his MD and PhD at the University of Buenos Aires, he pursued master’s courses in pharmacoepidemiology, clinical pharmacology, and biostatistics at the Universities of Toulouse, Bordeaux, and Paris. Dr Perez-Lloret is an Assistant Professor of Neurophysiology at the Medicine School of the University of Buenos Aires and a Senior Researcher at the Catholic University of Argentina, National Research Council. He is also an Associate Editor of BMC Neurology and a member of the Evidence-Based Medicine Committee of the International Parkinson’s Disease and Movement Disorder Society (MDS).

Wen-Jun Tu: Chinese Academy of Medical Sciences & Peking Union Medical College, China

Dr Wen-Jun Tu mainly engages in the following fields: prevention, diagnosis, prognosis, and rehabilitation of cerebrovascular diseases; development of biological kits; and construction of cerebrovascular disease biobanks. The future of his work is mainly focused on clinical applications of brain-computer interfaces. He has published more than 50 recent SCI-indexed papers with over 2,000 citations. He is an Associate Editor of several medical titles, including BMC Neurology.

About the collection

BMC Neurology is now welcoming submissions to a new Collection on biomarkers of neurological diseases and their potential in understanding, diagnosing, and managing various neurological conditions that impact millions of lives worldwide.

Neurological diseases, such as stroke, Parkinson’s disease, and multiple sclerosis pose significant challenges to individuals, their families, and healthcare systems. These conditions remain a significant public health concern, and as such, effective diagnostic tools, prognostic indicators, and personalized treatment strategies are in high demand. Measurable molecules and substances known as biomarkers hold immense promise in fulfilling these needs.

In this Collection, we invite submissions of cutting-edge original research offering novel perspectives on the identification, validation, and utilization of biomarkers in neurological diseases. We seek contributions that span a broad spectrum of disciplines, including genomics, proteomics, epidemiology, metabolomics, and transcriptomics. By embracing the synergistic power of these fields, we can harness the potential of biomarkers and grow closer to implementing them in clinical contexts.

Topics of interest to this Collection include, but are not limited to:

  •  Novel biomarkers for early detection and diagnosis of stroke, Parkinson’s disease, multiple sclerosis, or other neurological diseases
  •  Advancements in MRI, PET, or CT-based imaging biomarkers for neurologic disease detection and monitoring
  •  Using inflammatory markers as predictors of neurological disease progression and severity
  •  Oxidative stress as an indicator of neurodegeneration and potential targets for treatment response
  •  Using neurofilament proteins, tau protein, alpha-synuclein, and myelin-specific markers to diagnose the neuronal damage, degeneration, and myelin integrity associated with various neurological diseases
  •  The role of non-invasive biomarkers in neurology, such as blood-based or cerebrospinal fluid (CSF) biomarkers
  •  Challenges and opportunities in translating biomarker research to clinical practice

Image credit: Shidlovski / Getty Images / iStock

  1. Trimethylamine-N-oxide (TMAO), an intestinal microbiota-derived choline metabolite, has been found to be associated with ischemic stroke (IS) in more and more studies. However, the causal role of TMAO on IS oc...

    Authors: Xinhua Hu, Haiyan Ren and Yuan Cao
    Citation: BMC Neurology 2023 23:413
  2. A Phase I study showed that it is feasible to implement a home-based self-management program aimed at increasing physical activity in individuals after stroke with mild walking disability in Brazil. The next s...

    Authors: Maria Tereza Mota Alvarenga, Louise Ada, Elisabeth Preston, Lívia Cristina Guimarães Caetano, Luci Fuscaldi Teixeira-Salmela and Aline A Scianni
    Citation: BMC Neurology 2023 23:412

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Biomarkers of neurological diseases" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.